A Phase 1 Trial of Ruxolitinib, Lenalidomide and Methylprednisolone for Patients with Relapsed/Refractory Multiple Myeloma (MM)
- Resource Type
- Abstract
- Authors
- Berenson, James; To, Jennifer; Spektor, Tanya; Martinez, Daisy; Sanchez, Armando; Ghermezi, Matthew; Turner, Carley; Swift, Regina; Eades, Benjamin; Schwartz, Gary; Eshaghian, Shahrooz; Stampleman, Laura; Moss, Robert; Nassir, Youram; Patel, Ravindranath; Bessudo, Alberto; Lim, Stephen; Vescio, Robert
- Source
- In Clinical Lymphoma, Myeloma and Leukemia October 2019 19(10) Supplement:e249-e249
- Subject
- Language
- ISSN
- 2152-2650